{
    "code": "01027718",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01027718",
    "time": "2021-06-25 04:26:35",
    "許可證字號": "衛署藥製字第027718號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/07\/18",
    "發證日期": "73\/07\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102771805",
    "中文品名": "臨得隆注射液4毫克\/毫升（貝皮質醇）",
    "英文品名": "RINDERON INJECTION 4MG\/ML (BETAMETHASONE)",
    "適應症": "外科休克類似休克狀態、腦浮腫、副腎腫瘍摘除、關節風濕症、急性副腎不全、支氣管氣喘、風濕熱、結核性胸膜炎、結核性髓膜炎、腦脊髓炎、濕疹、天？瘡類、圓形脫毛症、過敏性結膜炎、鞏膜炎、虹彩炎、虹彩毛樣體炎、過敏性鼻炎、複合性副鼻腔炎。",
    "劑型": "270注射劑",
    "包裝": "0.5\/1毫升,100支以下玻璃安瓿裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BETAMETHASONE SODIUM PHOSPHATE",
    "限制項目": "01國　產",
    "申請商名稱": "1410301200  台灣塩野義製藥股份有限公司",
    "申請商地址": "台北市南京東路二段２號４樓",
    "主製造廠": [
        {
            "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
            "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804000231",
            "成分名稱": "BETAMETHASONE SODIUM PHOSPHATE",
            "含量描述": "(eq. to betamethasone 4mg)",
            "含量": "5.3000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "RD-INJ Vialv2-109-05-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=002&Type=10"
        },
        {
            "title": "RD-INJ-104-09-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "RD-Inj 擬妥仿單-110-04-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=007&Type=9"
        },
        {
            "title": "3. Rinderon-INS-108 (new)-108-05-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=006&Type=9"
        },
        {
            "title": "Rinderon injection PIv3-108-05-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=005&Type=9"
        },
        {
            "title": "3. RD-INJ PIv3_clean-108-02-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=004&Type=9"
        },
        {
            "title": "RD-INJ仿單擬稿-106-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=003&Type=9"
        },
        {
            "title": "Rinderon-INJ package insert D版(103年5月中旬開始)-104-09-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=002&Type=9"
        },
        {
            "title": "RD-INJ Labelv2-109-06-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=004&Type=8"
        },
        {
            "title": "Rinderon 標籤-106-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=003&Type=8"
        },
        {
            "title": "Rinderon 外盒-106-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=002&Type=8"
        },
        {
            "title": "RD-INJ Box-104-09-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=001&Type=8"
        }
    ]
}